Acknowledgements We thank the laboratory technicians in our animal unit at Novo Nordisk (Mlv, Denmark) for daily caretaking and for overseeing our experiments
Adv Sci 10:2204334 Liu Y, Gunda V, Zhu X, Xu X, Wu J, Askhatova D, Farokhzad OC, Parangi S, Shi J (2016) Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer
Conclusions KD demonstrates therapeutic potential in the management of a broad range of metabolic and neurological diseases
Get access for free Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing The Broader State of Pharmaceutical R&D and Innovation The pharmaceutical industry's research and development (R&D) landscape is undergoing dynamic shifts, influenced by funding trends, industry strategies, and scientific ambition
Clinical trial data shows that 48% of participants discontinued treatment due to gastrointestinal intolerance, though this rate drops significantly when dose escalation follows a slow, structured protocol
